Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
Símbolo de cotizaciónTNDM
Nombre de la empresaTandem Diabetes Care Inc
Fecha de salida a bolsaNov 13, 2013
Fundada en2008
Director ejecutivoMr. John F. Sheridan
Número de empleados2650
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 13
Dirección12400 High Bluff Drive
CiudadSAN DIEGO
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal92130
Teléfono18583666900
Sitio Webhttps://www.tandemdiabetes.com/
Símbolo de cotizaciónTNDM
Fecha de salida a bolsaNov 13, 2013
Fundada en2008
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos